Success Rates in Smoking Cessation: Psychological Preparation Plays a Critical Role and Interacts with Other Factors Such As Psychoactive Substances
Overview
Authors
Affiliations
Introduction: The aim of this study was to identify factors associated with the results of smoking cessation attempts.
Methods: Data were collected in Clermont-Ferrand from a smoking cessation clinic between 1999 and 2009 (1,361 patients). Smoking cessation was considered a success when patients were abstinent 6 months after the beginning of cessation. Multivariate logistic regression was used to investigate the association between abstinence and different factors.
Results: The significant factors were a history of depression (ORadjusted = 0.57, p = 0.003), state of depression at the initial consultation (ORa = 0.64, p = 0.005), other psychoactive substances (ORa = 0.52, p<0.0001), heart, lung and Ear-Nose-Throat diseases (ORa = 0.65, p = 0.005), age (ORa = 1.04, p<0.0001), the Richmond test (p<0.0001; when the patient's motivation went from insufficient to moderate, the frequency of abstinence was twice as high) and the Prochaska algorithm (p<0.0001; when the patient went from the 'pre-contemplation' to the 'contemplation' level, the frequency of success was four times higher). A high score in the Richmond test had a greater impact on success with increasing age (significant interaction: p = 0.01). In exclusive smokers, the contemplation level in the Prochaska algorithm was enough to obtain a satisfactory abstinence rate (65.5%) whereas among consumers of other psychoactive substances, it was necessary to reach the preparation level in the Prochaska algorithm to achieve a success rate greater than 50% (significant interaction: p = 0.02).
Conclusion: The psychological preparation of the smoker plays a critical role. The management of smoking cessation must be personalized, especially for consumers of other psychoactive substances and/or smokers with a history of depression.
Di Prinzio R, Bondanini G, De Falco F, Vinci M, Camisa V, Santoro A Ann Glob Health. 2023; 89(1):56.
PMID: 37663224 PMC: 10473173. DOI: 10.5334/aogh.4153.
Effectiveness of a Smoking Cessation Program during the COVID-19 Pandemic.
Kruk A, Czerwinska C, Dolna-Michno J, Broniatowska E, Kolanko E Healthcare (Basel). 2023; 11(11).
PMID: 37297676 PMC: 10252602. DOI: 10.3390/healthcare11111536.
Al-Dahshan A, Al Muraikhi H, Musa S, Joudeh A, Al Baker W, Selim N Front Public Health. 2023; 11:1166016.
PMID: 37275499 PMC: 10235512. DOI: 10.3389/fpubh.2023.1166016.
Choo S, Chang C, Tangiisuran B, Latif M, Sanusi N, Harun S Int J Environ Res Public Health. 2022; 19(13).
PMID: 35805417 PMC: 9265789. DOI: 10.3390/ijerph19137757.
Smoking Cessation at the Community Pharmacy: Determinants of Success from a Real-Life Practice.
Condinho M, Ramalhinho I, Sinogas C Pharmacy (Basel). 2021; 9(3).
PMID: 34449711 PMC: 8396305. DOI: 10.3390/pharmacy9030143.